文献速递糖尿病

数据驱动的症状前1型糖尿病表型分析:基于纵向自身抗体谱

Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles.
PubMed 文献 · Diabetes Care · 2024-01-01

T1DI研究纳入1845名遗传易感且至少一种胰岛自身抗体阳性的前瞻性观察儿童,用无监督层次聚类分析纵向自身抗体谱,识别出5个主要聚类,其5年进展至1型糖尿病风险从1.6%到69.9%不等,10年风险最高达89.9%。

要点

  • 早期出现IAA、继而GADA、再IA-2A的儿童5年风险最高,达69.9%。
  • 持续IAA和GADA阳性儿童5年风险为39.1%,持续GADA和IA-2A阳性为30.9%。
  • 单个、常可转阴的自身抗体阳性儿童5年风险最低,为1.6%。

核心结论

  • 新型聚类算法识别出具有不同胰岛自身抗体谱和糖尿病进展速率的儿童,结果可用于预测、选择预防试验个体及研究1型糖尿病不同路径。

研究设计与样本

  • T1DI研究合并1845名遗传易感、前瞻性观察且至少一种胰岛自身抗体(IAA、GADA或IA-2A)阳性儿童的数据。
  • 采用考虑个体时间自身抗体谱、抗体出现年龄和抗体类型阳性变异的新型相似性算法,进行无监督层次聚类分析。
  • 通过生存分析评估进展至糖尿病的速率。

主要发现

  • 从首次自身抗体阳性至1型糖尿病的最高5年风险为69.9%(95% CI 60.0-79.2),见于生命早期先出现IAA(中位年龄1.6岁)、随后GADA(1.9岁)、再IA-2A(2.1岁)的儿童,其10年风险为89.9%(95% CI 81.9-95.4)。
  • 持续IAA和GADA阳性儿童的5年风险为39.1%,持续GADA和IA-2A阳性儿童为30.9%。
  • 晚出现持续GADA(6.1岁)儿童的5年风险较低,为10.5%。
  • 单个、常可转阴的自身抗体阳性与最低5年糖尿病风险相关,为1.6%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize distinct islet autoantibody profiles preceding stage 3 type 1 diabetes. RESEARCH DESIGN AND METHODS: The T1DI (Type 1 Diabetes Intelligence) study combined data from 1,845 genetically susceptible prospectively observed children who were positive for at least one islet autoantibody: insulin autoantibody (IAA), GAD antibody (GADA), or islet antigen 2 antibody (IA-2A). Using a novel similarity algorithm that considers an individual's temporal autoantibody profile, age at autoantibody appearance, and variation in the positivity of autoantibody types, we performed an unsupervised hierarchical clustering analysis. Progression rates to diabetes were analyzed via survival analysis. RESULTS: We identified five main clusters of individuals with distinct autoantibody profiles characterized by seroconversion age and sequence of appearance of the three autoantibodies. The highest 5-year risk from first positive autoantibody to type 1 diabetes (69.9%; 95% CI 60.0-79.2) was observed in children who first developed IAA in early life (median age 1.6 years) followed by GADA (1.9 years) and then IA-2A (2.1 years). Their 10-year risk was 89.9% (95% CI 81.9-95.4). A high 5-year risk was also found in children with persistent IAA and GADA (39.1%) and children with persistent GADA and IA-2A (30.9%). A lower 5-year risk (10.5%) was observed in children with a late appearance of persistent GADA (6.1 years). The lowest 5-year diabetes risk (1.6%) was associated with positivity for a single, often reverting, autoantibody. CONCLUSIONS: The novel clustering algorithm identified children with distinct islet autoantibody profiles and progression rates to diabetes. These results are useful for prediction, selection of individuals for prevention trials, and studies investigating various pathways to type 1 diabetes.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Ghalwash M, Anand V, Ng K, et al. Data-Driven Phenotyping of Presymptomatic Type 1 Diabetes Using Longitudinal Autoantibody Profiles. Diabetes Care. 2024. PMID: 38861550. doi:10.2337/dc24-0198

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。